Hexal Australia Pty Ltd v Roche Therapeutics Inc
|
[2005] FCA 1218; (2005) 66 IPR 325
|
Federal Court of Australia
|
Australia - Commonwealth
|
31 Aug 2005
|
AustLII
|
|
40
|
Merck & Co Inc v Arrow Pharmaceuticals Ltd
|
[2005] FCA 425
|
Federal Court of Australia
|
Australia - Commonwealth
|
13 Apr 2005
|
AustLII
|
|
1
|
Arrow Pharmaceuticals Ltd v Merck & Co Inc
|
[2005] FCA 188
|
Federal Court of Australia
|
Australia - Commonwealth
|
9 Mar 2005
|
AustLII
|
|
4
|
Pfizer Inc v Commissioner of Patents
|
[2005] FCA 137; (2005) 141 FCR 413; 64 IPR 547; [2005] AIPC 92-075
|
Federal Court of Australia
|
Australia - Commonwealth
|
1 Mar 2005
|
AustLII
|
|
25
|
Australia-United States Free Trade Agreement
|
[2005] ATS 1
|
|
Australia
|
circa 2005
|
AustLII
|
|
51
|
R (On the Application of Merck Sharp & Dohme Ltd) v Licensing Authority
|
[2005] EWHC 710
|
High Court of England and Wales
|
United Kingdom - England and Wales
|
circa 2005
|
BAILII
|
|
|
Imperial Chemicals Industries Pty Ltd v Commissioner of Patents
|
[2004] FCA 1658; (2004) 213 ALR 399; (2004) 63 IPR 476; [2005] AIPC 92-055
|
Federal Court of Australia
|
Australia - Commonwealth
|
13 Dec 2004
|
AustLII
|
|
24
|
Arrow Pharmaceuticals Ltd v Merck & Co Inc
|
[2004] FCA 1282; (2004) 213 ALR 182; (2004) 63 IPR 85; [2004] AIPC 92-034; [2005] ALMD 1086
|
Federal Court of Australia
|
Australia - Commonwealth
|
6 Oct 2004
|
AustLII
|
|
26
|
"The United States-Australia Free Trade Agreement – the intellectual property chapter"
|
(2004) 15 Australian Intellectual Property Journal 205
|
Australian Intellectual Property Journal
|
Australia
|
circa 2004
|
Legal Online
|
|
6
|
Smithkline Beechham plc v Lek Pharmaceutical & Chemcial Co DD
|
61 IPR 626; [2004] AIPC 91-993
|
|
Australia
|
circa 2004
|
LexisNexis AU
|
|
1
|
Nimmo v Habton Farms
|
[2003] EWCA Civ 1545; [2004] QB 1; [2003] 1 All ER 1136; [2004] IP & T 674; [2003] 3 WLR 633; [2003] 2 All ER (Comm) 109; [2003] All ER (D) 62
|
England and Wales Court of Appeal - Civil Division
|
United Kingdom - England and Wales
|
6 Feb 2003
|
BAILII
|
|
11
|
(2003) 33 Seton Hall Law Review 479
|
(2003) 33 Seton Hall Law Review 479
|
Seton Hall Law Review
|
United States
|
circa 2003
|
HeinOnline / LexisNexis
|
|
1
|
Merck & Co , Inc ’ s Patents
|
[2003] EWHC 5
|
High Court of England and Wales
|
United Kingdom - England and Wales
|
circa 2003
|
BAILII
|
|
|
Aktiebolaget Hassle v Alphapharm Pty Ltd
|
[2002] HCA 59; (2002) 212 CLR 411; (2002) 194 ALR 485; (2002) 56 IPR 129; (2002) 77 ALJR 398; [2003] AIPC 91-838
|
High Court of Australia
|
Australia - Commonwealth
|
12 Dec 2002
|
AustLII
|
|
564
|
Cairnstores Ltd, Generics (UK) Ltd v Aktiebolaget H ä ssle
|
[2002] EWHC 309
|
High Court of England and Wales
|
United Kingdom - England and Wales
|
circa 2002
|
BAILII
|
|
1
|
Boehringer Ingelheim International GmbH v Commissioner of Patents
|
[2001] FCA 647; (2001) 112 FCR 595; 52 IPR 529
|
Federal Court of Australia
|
Australia - Commonwealth
|
6 Jun 2001
|
AustLII
|
|
32
|
"Stretching the Limits of Intellectual Property Rights: Has the Pharmaceutical Industry Gone Too Far?"
|
(2001) 41 IDEA The Journal of Law and Technology 227
|
IDEA: The Journal of Law and Technology
|
United States
|
circa 2001
|
|
|
1
|
Boehringer Ingelheim International v Commissioner of Patents
|
[2000] FCA 1918; [2001] AIPC 91-670
|
Federal Court of Australia
|
Australia - Commonwealth
|
22 Dec 2000
|
AustLII
|
|
21
|
Aktiebolaget H ä ssle v Alphapharm Pty Ltd
|
[2000] FCA 1303; (2000) 51 IPR 375; [2000] AIPC 38,162
|
Federal Court of Australia
|
Australia - Commonwealth
|
9 Oct 2000
|
AustLII
|
|
34
|
Bristol-Myers Squibb v Baker Norton Pharmaceuticals Inc
|
[2000] EWCA Civ 169; (2001) 58 BMLR 121; [2001] RPC 1; [2000] IP & T 908; [2000] All ER (D) 713
|
England and Wales Court of Appeal - Civil Division
|
United Kingdom - England and Wales
|
23 May 2000
|
BAILII
|
|
38
|
Bristol-Myers Squibb Co v FH Faulding & Co Ltd
|
[2000] FCA 316; (2000) 97 FCR 524; (2000) 170 ALR 439; (2000) 46 IPR 553; [2000] AIPC 37,298
|
Federal Court of Australia
|
Australia - Commonwealth
|
22 Mar 2000
|
AustLII
|
|
304
|
Hatch-Waxman and the
|
(1999) 54 Food and Drug Law Journal 245
|
Food and Drug Law Journal
|
United States
|
circa 1999
|
HeinOnline / LexisNexis
|
|
1
|
(1999) 54 Food and Drug Law Journal 185
|
(1999) 54 Food and Drug Law Journal 185
|
Food and Drug Law Journal
|
United States
|
circa 1999
|
HeinOnline / LexisNexis
|
|
1
|
"Overview of the Hatch-Waxman Act and Its Impact on the Drug Development Process"
|
(1999) 54 Food and Drug Law Journal 187
|
Food and Drug Law Journal
|
United States
|
circa 1999
|
HeinOnline / LexisNexis
|
|
3
|
(1999) 54 Food and Drug Law Journal 195
|
(1999) 54 Food and Drug Law Journal 195
|
Food and Drug Law Journal
|
United States
|
circa 1999
|
HeinOnline / LexisNexis
|
|
2
|
Bristol-Myers Squibb Co v FH Faulding & Co Ltd
|
(1998) 41 IPR 467; [1998] AIPC 37,540
|
|
|
circa 1998
|
LexisNexis AU
|
|
21
|
Anaesthetic Supplies Pty Ltd v Rescare Ltd
|
[1994] FCA 1065; (1994) 50 FCR 1; (1994) 122 ALR 141; [1994] AIPC 91-076; 28 IPR 383
|
Federal Court of Australia
|
Australia - Commonwealth
|
5 May 1994
|
AustLII
|
|
76
|
Gats
|
(1994) 1867 UNTS 3
|
|
International
|
circa 1994
|
|
|
143
|
Roche Products, Inc v Bolar Pharmaceutical Co
|
733 F2d 858; 221 USPQ 937
|
United States Court of Appeals, Federal Circuit
|
United States
|
23 Apr 1984
|
WorldLII
|
|
45
|
Wellcome Foundation Ltd v Commissioner of Patents
|
[1983] NZLR 385; (1983) 2 IPR 156
|
|
New Zealand
|
circa 1983
|
LexisNexis
|
|
33
|
(1967) 828 Unts 305
|
(1967) 828 UNTS 305
|
|
International
|
circa 1967
|
|
|
15
|
Statute of Monopolies 1623
|
23 Jac 1
|
Court of Chancery
|
United Kingdom
|
circa 1999
|
|
|
7
|
See Merck KGaA v Integra Lifesciences I, Ltd
|
545 US 193; 125 SCt 2372; 162 L Ed 2d 160
|
United States Supreme Court
|
United States
|
circa 1999
|
Westlaw
|
|
11
|
Re Pfizer Inc
|
62 IPR 627; [2004] AIPC 92-009
|
|
|
circa 1999
|
LexisNexis AU
|
|
1
|